An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

Investigational Site (434), Vienna

Investigational Site (433), Grålum

Investigational Site (519), Concord

Investigational Site (409), Westmead

Investigational Site (413), Liverpool

Investigational Site (410), Box Hill

Investigational Site (517), Douglas

Investigational Site (407), West Perth

Investigational Site (437), Trondheim

Investigational Site (429), Burgos

Investigational Site (421), New York

Investigational Site (404), New York

Investigational Site (422), The Bronx

Investigational Site (423), New Hyde Park

Investigational site (405), Lake Success

Investigational Site (420), Shirley

Investigational Site (401), Washington D.C.

Investigational Site (428), Milan

Investigational Site (435), Columbia

Investigational Site (402), Greenville

Investigational Site (430), Madrid

Investigational Site (431), Novara

Investigational Site (414), Charlotte

Investigational Site (426), Murcia

Investigational Site (419), Cooper City

Investigational Site (425), Miami

Investigational Site (443), Trieste

Investigational Site (418), Istanbul

Investigational Site (427), Seville

Investigational Site (438), Essen

Investigational Site (432), Meldola

Investigational Site (219), Iowa City

Investigational Site (230), Los Angeles

Investigational Site (411), Seattle

Investigational Site (406), Greenfield Park

Investigational Site (403), Hamilton

Investigational Site (444), Toronto

Investigational Site (436), Barcelona

Investigational Site (415), Ankara

Investigational Site (416), Ankara

Investigational Site (442), Leeds

Investigational Site (441), London

Investigational Site (439), London

Investigational Site (440), London